{"transactions":[{"id":3076948,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-07-23T19:43:45.000Z","date":"2020-07-22","kind":"exercise","acquired":false,"shares":30772,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"Options to purchase 67,586 ordinary shares will vest and become exercisable in equal installments on each of 2/26/21 and 2/26/22, subject to the reporting person's continued employment through such dates."}],"balance_after":67586,"derivative":{"exercise_price":21.15,"expiration_date":"2028-02-26","underlying":"Ordinary Shares","underlying_shares":30772},"source":{"system":"sec-edgar","filing":"0001645113-20-000101","document":"wf-form4_159554780981314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000101/wf-form4_159554780981314.xml","form_type":"4"}},{"id":3076947,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-07-23T19:43:45.000Z","date":"2020-07-22","kind":"exercise","acquired":false,"shares":3774,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":11.46,"expiration_date":"2026-02-24","underlying":"Ordinary Shares","underlying_shares":3774},"source":{"system":"sec-edgar","filing":"0001645113-20-000101","document":"wf-form4_159554780981314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000101/wf-form4_159554780981314.xml","form_type":"4"}},{"id":3076946,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-07-23T19:43:45.000Z","date":"2020-07-22","kind":"exercise","acquired":false,"shares":8426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":11.46,"expiration_date":"2026-02-24","underlying":"Ordinary Shares","underlying_shares":8426},"source":{"system":"sec-edgar","filing":"0001645113-20-000101","document":"wf-form4_159554780981314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000101/wf-form4_159554780981314.xml","form_type":"4"}},{"id":3076945,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-07-23T19:43:45.000Z","date":"2020-07-21","kind":"exercise","acquired":false,"shares":3021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Fully-vested as of the date hereof except for options to purchase 67,586 ordinary shares, which will vest in equal installments on each of 2/26/21 and 2/26/22, subject to the reporting person's continued employment through such dates."}],"balance_after":98358,"derivative":{"exercise_price":21.15,"expiration_date":"2028-02-26","underlying":"Ordinary Shares","underlying_shares":3021},"source":{"system":"sec-edgar","filing":"0001645113-20-000101","document":"wf-form4_159554780981314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000101/wf-form4_159554780981314.xml","form_type":"4"}},{"id":3076944,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-07-23T19:43:45.000Z","date":"2020-07-21","kind":"exercise","acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Fully vested as of the date hereof."}],"balance_after":8426,"derivative":{"exercise_price":11.46,"expiration_date":"2026-02-24","underlying":"Ordinary Shares","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0001645113-20-000101","document":"wf-form4_159554780981314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000101/wf-form4_159554780981314.xml","form_type":"4"}},{"id":3076943,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-07-23T19:43:45.000Z","date":"2020-07-22","kind":"sale","acquired":false,"shares":17175,"price":67.393,"value":1157474.775,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 17,175 shares in multiple trades at prices ranging from $67.04 to $67.94.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":220867,"source":{"system":"sec-edgar","filing":"0001645113-20-000101","document":"wf-form4_159554780981314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000101/wf-form4_159554780981314.xml","form_type":"4"}},{"id":3076942,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-07-23T19:43:45.000Z","date":"2020-07-22","kind":"sale","acquired":false,"shares":12217,"price":66.656,"value":814336.352,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 12,217 shares in multiple trades at prices ranging from $66.03 to $67.02.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":238042,"source":{"system":"sec-edgar","filing":"0001645113-20-000101","document":"wf-form4_159554780981314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000101/wf-form4_159554780981314.xml","form_type":"4"}},{"id":3076941,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-07-23T19:43:45.000Z","date":"2020-07-22","kind":"sale","acquired":false,"shares":1380,"price":65.489,"value":90374.82,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 1,380 shares in multiple trades at prices ranging from $65.00 to $65.92.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":250259,"source":{"system":"sec-edgar","filing":"0001645113-20-000101","document":"wf-form4_159554780981314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000101/wf-form4_159554780981314.xml","form_type":"4"}},{"id":3076940,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-07-23T19:43:45.000Z","date":"2020-07-22","kind":"exercise","acquired":true,"shares":30772,"price":21.15,"value":650827.8,"ownership":{"direct":true},"balance_after":251639,"source":{"system":"sec-edgar","filing":"0001645113-20-000101","document":"wf-form4_159554780981314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000101/wf-form4_159554780981314.xml","form_type":"4"}},{"id":3076939,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-07-23T19:43:45.000Z","date":"2020-07-22","kind":"sale","acquired":false,"shares":2623,"price":67.278,"value":176470.194,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 2,623 shares in multiple trades at prices ranging from $66.79 to $67.64.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":220867,"source":{"system":"sec-edgar","filing":"0001645113-20-000101","document":"wf-form4_159554780981314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000101/wf-form4_159554780981314.xml","form_type":"4"}},{"id":3076938,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-07-23T19:43:45.000Z","date":"2020-07-22","kind":"sale","acquired":false,"shares":1151,"price":66.498,"value":76539.198,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On July 21, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 1,151 shares in multiple trades at prices ranging from $65.76 to $66.75.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":223490,"source":{"system":"sec-edgar","filing":"0001645113-20-000101","document":"wf-form4_159554780981314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000101/wf-form4_159554780981314.xml","form_type":"4"}},{"id":3076937,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-07-23T19:43:45.000Z","date":"2020-07-22","kind":"exercise","acquired":true,"shares":3774,"price":11.46,"value":43250.04,"ownership":{"direct":true},"balance_after":224641,"source":{"system":"sec-edgar","filing":"0001645113-20-000101","document":"wf-form4_159554780981314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000101/wf-form4_159554780981314.xml","form_type":"4"}},{"id":3076936,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-07-23T19:43:45.000Z","date":"2020-07-22","kind":"sale","acquired":false,"shares":3798,"price":67.476,"value":256273.848,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 3,798 shares in multiple trades at prices ranging from $67.21 to $67.80.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":220867,"source":{"system":"sec-edgar","filing":"0001645113-20-000101","document":"wf-form4_159554780981314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000101/wf-form4_159554780981314.xml","form_type":"4"}},{"id":3076935,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-07-23T19:43:45.000Z","date":"2020-07-22","kind":"sale","acquired":false,"shares":4228,"price":66.766,"value":282286.648,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 4,228 shares in multiple trades at prices ranging from $66.21 to $67.19.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":224665,"source":{"system":"sec-edgar","filing":"0001645113-20-000101","document":"wf-form4_159554780981314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000101/wf-form4_159554780981314.xml","form_type":"4"}},{"id":3076934,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-07-23T19:43:45.000Z","date":"2020-07-22","kind":"sale","acquired":false,"shares":400,"price":65.525,"value":26210.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 400 shares in multiple trades at prices ranging from $65.16 to $65.82.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":228893,"source":{"system":"sec-edgar","filing":"0001645113-20-000101","document":"wf-form4_159554780981314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000101/wf-form4_159554780981314.xml","form_type":"4"}},{"id":3076933,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-07-23T19:43:45.000Z","date":"2020-07-22","kind":"exercise","acquired":true,"shares":8426,"price":11.46,"value":96561.96,"ownership":{"direct":true},"balance_after":229293,"source":{"system":"sec-edgar","filing":"0001645113-20-000101","document":"wf-form4_159554780981314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000101/wf-form4_159554780981314.xml","form_type":"4"}},{"id":3076932,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-07-23T19:43:45.000Z","date":"2020-07-21","kind":"sale","acquired":false,"shares":3021,"price":65.062,"value":196552.302,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 21, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 3,021 shares in multiple trades at prices ranging from $65.00 to $65.31.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":220867,"source":{"system":"sec-edgar","filing":"0001645113-20-000101","document":"wf-form4_159554780981314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000101/wf-form4_159554780981314.xml","form_type":"4"}},{"id":3076931,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-07-23T19:43:45.000Z","date":"2020-07-21","kind":"exercise","acquired":true,"shares":3021,"price":21.15,"value":63894.15,"ownership":{"direct":true},"balance_after":223888,"source":{"system":"sec-edgar","filing":"0001645113-20-000101","document":"wf-form4_159554780981314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000101/wf-form4_159554780981314.xml","form_type":"4"}},{"id":3076930,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-07-23T19:43:45.000Z","date":"2020-07-21","kind":"sale","acquired":false,"shares":300,"price":65.067,"value":19520.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 21, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 300 shares in multiple trades at prices ranging from $65.00 to $65.11.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":220867,"source":{"system":"sec-edgar","filing":"0001645113-20-000101","document":"wf-form4_159554780981314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000101/wf-form4_159554780981314.xml","form_type":"4"}},{"id":3076929,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-07-23T19:43:45.000Z","date":"2020-07-21","kind":"exercise","acquired":true,"shares":300,"price":11.46,"value":3438.0,"ownership":{"direct":true},"balance_after":221167,"source":{"system":"sec-edgar","filing":"0001645113-20-000101","document":"wf-form4_159554780981314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000101/wf-form4_159554780981314.xml","form_type":"4"}},{"id":3176524,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-04-15T17:03:29.000Z","date":"2020-04-14","kind":"exercise","acquired":false,"shares":35745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested as of the date hereof."}],"balance_after":44514,"derivative":{"exercise_price":7.15,"expiration_date":"2027-02-21","underlying":"Ordinary Shares","underlying_shares":35745},"source":{"system":"sec-edgar","filing":"0001645113-20-000051","document":"wf-form4_158698459073166.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000051/wf-form4_158698459073166.xml","form_type":"4"}},{"id":3176523,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-04-15T17:03:29.000Z","date":"2020-04-13","kind":"exercise","acquired":false,"shares":22755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested as of the date hereof."}],"balance_after":80259,"derivative":{"exercise_price":7.15,"expiration_date":"2027-02-21","underlying":"Ordinary Shares","underlying_shares":22755},"source":{"system":"sec-edgar","filing":"0001645113-20-000051","document":"wf-form4_158698459073166.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000051/wf-form4_158698459073166.xml","form_type":"4"}},{"id":3176522,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-04-15T17:03:29.000Z","date":"2020-04-14","kind":"sale","acquired":false,"shares":377,"price":71.753,"value":27050.881,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On April 14, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 377 shares in multiple trades at prices ranging from $71.64 to $71.88.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":220867,"source":{"system":"sec-edgar","filing":"0001645113-20-000051","document":"wf-form4_158698459073166.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000051/wf-form4_158698459073166.xml","form_type":"4"}},{"id":3176521,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-04-15T17:03:29.000Z","date":"2020-04-14","kind":"sale","acquired":false,"shares":27142,"price":70.994,"value":1926919.148,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On April 14, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 27,142 shares in multiple trades at prices ranging from $70.62 to $71.51.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":221244,"source":{"system":"sec-edgar","filing":"0001645113-20-000051","document":"wf-form4_158698459073166.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000051/wf-form4_158698459073166.xml","form_type":"4"}},{"id":3176520,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-04-15T17:03:29.000Z","date":"2020-04-13","kind":"sale","acquired":false,"shares":8226,"price":70.182,"value":577317.132,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On April 14, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 8,226 shares in multiple trades at prices ranging from $69.62 to $70.61.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":248386,"source":{"system":"sec-edgar","filing":"0001645113-20-000051","document":"wf-form4_158698459073166.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000051/wf-form4_158698459073166.xml","form_type":"4"}},{"id":3176519,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-04-15T17:03:29.000Z","date":"2020-04-14","kind":"exercise","acquired":true,"shares":35745,"price":7.15,"value":255576.75,"ownership":{"direct":true},"balance_after":256612,"source":{"system":"sec-edgar","filing":"0001645113-20-000051","document":"wf-form4_158698459073166.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000051/wf-form4_158698459073166.xml","form_type":"4"}},{"id":3176518,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-04-15T17:03:29.000Z","date":"2020-04-13","kind":"sale","acquired":false,"shares":22755,"price":69.008,"value":1570277.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 13, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 22,755 shares in multiple trades at prices ranging from $69.00 to $69.42.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":220867,"source":{"system":"sec-edgar","filing":"0001645113-20-000051","document":"wf-form4_158698459073166.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000051/wf-form4_158698459073166.xml","form_type":"4"}},{"id":3176517,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-04-15T17:03:29.000Z","date":"2020-04-13","kind":"exercise","acquired":true,"shares":22755,"price":7.15,"value":162698.25,"ownership":{"direct":true},"balance_after":243622,"source":{"system":"sec-edgar","filing":"0001645113-20-000051","document":"wf-form4_158698459073166.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000051/wf-form4_158698459073166.xml","form_type":"4"}},{"id":3217885,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Share Units","published_at":"2020-03-10T16:22:15.000Z","date":"2020-03-06","kind":"sale","acquired":false,"shares":2274,"price":69.534,"value":158120.316,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units vested on March 5, 2020.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":220867,"source":{"system":"sec-edgar","filing":"0001645113-20-000050","document":"wf-form4_158387171792410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000050/wf-form4_158387171792410.xml","form_type":"4"}},{"id":3224570,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-03-05T18:55:01.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":27794,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 27,794 ordinary shares will vest and become exercisable in equal installments on each of March 3, 2021, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates."}],"balance_after":27794,"derivative":{"exercise_price":69.37,"expiration_date":"2030-03-02","underlying":"Ordinary Shares","underlying_shares":27794},"source":{"system":"sec-edgar","filing":"0001645113-20-000039","document":"wf-form4_158345248438324.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000039/wf-form4_158345248438324.xml","form_type":"4"}},{"id":3224569,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Share Units","published_at":"2020-03-05T18:55:01.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":14415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest on March 3, 2021, 2022 and 2023, subject to the reporting person's continued employment through such dates."}],"balance_after":223141,"source":{"system":"sec-edgar","filing":"0001645113-20-000039","document":"wf-form4_158345248438324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000039/wf-form4_158345248438324.xml","form_type":"4"}},{"id":3238250,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2020-03-02T17:17:13.000Z","date":"2020-02-27","kind":"exercise","acquired":false,"shares":6173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":6172,"derivative":{"exercise_price":0,"exercise_date":"2020-02-27","underlying":"Ordinary Shares","underlying_shares":6173},"source":{"system":"sec-edgar","filing":"0001645113-20-000033","document":"wf-form4_158318741628984.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000033/wf-form4_158318741628984.xml","form_type":"4"}},{"id":3238249,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-02T17:17:13.000Z","date":"2020-02-28","kind":"sale","acquired":false,"shares":2673,"price":72.215,"value":193030.695,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":208726,"source":{"system":"sec-edgar","filing":"0001645113-20-000033","document":"wf-form4_158318741628984.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000033/wf-form4_158318741628984.xml","form_type":"4"}},{"id":3238248,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-02T17:17:13.000Z","date":"2020-02-27","kind":"exercise","acquired":true,"shares":6173,"price":79.45,"value":490444.85,"ownership":{"direct":true},"balance_after":211399,"source":{"system":"sec-edgar","filing":"0001645113-20-000033","document":"wf-form4_158318741628984.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000033/wf-form4_158318741628984.xml","form_type":"4"}},{"id":3246391,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2020-02-26T17:10:41.000Z","date":"2020-02-24","kind":"exercise","acquired":false,"shares":31199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2020-02-22","underlying":"Ordinary Shares","underlying_shares":31199},"source":{"system":"sec-edgar","filing":"0001645113-20-000012","document":"wf-form4_158275502371144.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000012/wf-form4_158275502371144.xml","form_type":"4"}},{"id":3246390,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-26T17:10:41.000Z","date":"2020-02-25","kind":"sale","acquired":false,"shares":11647,"price":81.156,"value":945223.932,"ownership":{"direct":true},"balance_after":205226,"source":{"system":"sec-edgar","filing":"0001645113-20-000012","document":"wf-form4_158275502371144.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000012/wf-form4_158275502371144.xml","form_type":"4"}},{"id":3246389,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-26T17:10:41.000Z","date":"2020-02-24","kind":"exercise","acquired":true,"shares":31199,"price":88.26,"value":2753623.74,"ownership":{"direct":true},"balance_after":216873,"source":{"system":"sec-edgar","filing":"0001645113-20-000012","document":"wf-form4_158275502371144.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000164511320000012/wf-form4_158275502371144.xml","form_type":"4"}},{"id":3378795,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-11-06T16:27:40.000Z","date":"2019-11-04","kind":"exercise","acquired":false,"shares":33793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":96651,"derivative":{"exercise_price":21.15,"expiration_date":"2028-02-26","underlying":"Ordinary Shares","underlying_shares":33793},"source":{"system":"sec-edgar","filing":"0001628280-19-013505","document":"wf-form4_157307564482872.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000162828019013505/wf-form4_157307564482872.xml","form_type":"4"}},{"id":3378794,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-11-06T16:27:40.000Z","date":"2019-11-04","kind":"exercise","acquired":false,"shares":36957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":22,"expiration_date":"2025-10-01","underlying":"Ordinary Shares","underlying_shares":36957},"source":{"system":"sec-edgar","filing":"0001628280-19-013505","document":"wf-form4_157307564482872.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000162828019013505/wf-form4_157307564482872.xml","form_type":"4"}},{"id":3378793,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-11-06T16:27:40.000Z","date":"2019-11-04","kind":"exercise","acquired":false,"shares":10069,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":14.37,"expiration_date":"2025-02-23","underlying":"Ordinary Shares","underlying_shares":10069},"source":{"system":"sec-edgar","filing":"0001628280-19-013505","document":"wf-form4_157307564482872.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000162828019013505/wf-form4_157307564482872.xml","form_type":"4"}},{"id":3378792,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-11-06T16:27:40.000Z","date":"2019-11-04","kind":"sale","acquired":false,"shares":33793,"price":79,"value":2669647.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi."}],"balance_after":185674,"source":{"system":"sec-edgar","filing":"0001628280-19-013505","document":"wf-form4_157307564482872.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000162828019013505/wf-form4_157307564482872.xml","form_type":"4"}},{"id":3378791,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-11-06T16:27:40.000Z","date":"2019-11-04","kind":"exercise","acquired":true,"shares":33793,"price":21.15,"value":714721.95,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi."}],"balance_after":219467,"source":{"system":"sec-edgar","filing":"0001628280-19-013505","document":"wf-form4_157307564482872.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000162828019013505/wf-form4_157307564482872.xml","form_type":"4"}},{"id":3378790,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-11-06T16:27:40.000Z","date":"2019-11-04","kind":"sale","acquired":false,"shares":36957,"price":79,"value":2919603.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi."}],"balance_after":185674,"source":{"system":"sec-edgar","filing":"0001628280-19-013505","document":"wf-form4_157307564482872.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000162828019013505/wf-form4_157307564482872.xml","form_type":"4"}},{"id":3378789,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-11-06T16:27:40.000Z","date":"2019-11-04","kind":"exercise","acquired":true,"shares":36957,"price":22,"value":813054.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi."}],"balance_after":222631,"source":{"system":"sec-edgar","filing":"0001628280-19-013505","document":"wf-form4_157307564482872.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000162828019013505/wf-form4_157307564482872.xml","form_type":"4"}},{"id":3378788,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-11-06T16:27:40.000Z","date":"2019-11-04","kind":"sale","acquired":false,"shares":10069,"price":79,"value":795451.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi."}],"balance_after":185674,"source":{"system":"sec-edgar","filing":"0001628280-19-013505","document":"wf-form4_157307564482872.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000162828019013505/wf-form4_157307564482872.xml","form_type":"4"}},{"id":3378787,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-11-06T16:27:40.000Z","date":"2019-11-04","kind":"exercise","acquired":true,"shares":10069,"price":14.37,"value":144691.53,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi."}],"balance_after":195743,"source":{"system":"sec-edgar","filing":"0001628280-19-013505","document":"wf-form4_157307564482872.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000162828019013505/wf-form4_157307564482872.xml","form_type":"4"}},{"id":3481462,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-06-21T16:01:53.000Z","date":"2019-06-19","kind":"exercise","acquired":false,"shares":110868,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":36957,"derivative":{"exercise_price":22,"expiration_date":"2025-10-01","underlying":"Ordinary Shares","underlying_shares":110868},"source":{"system":"sec-edgar","filing":"0001209191-19-038446","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119038446/doc4.xml","form_type":"4"}},{"id":3481461,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-06-21T16:01:53.000Z","date":"2019-06-19","kind":"sale","acquired":false,"shares":110868,"price":60,"value":6652080.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi."}],"balance_after":185674,"source":{"system":"sec-edgar","filing":"0001209191-19-038446","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119038446/doc4.xml","form_type":"4"}},{"id":3481460,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-06-21T16:01:53.000Z","date":"2019-06-19","kind":"exercise","acquired":true,"shares":110868,"price":22,"value":2439096.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi."}],"balance_after":296542,"source":{"system":"sec-edgar","filing":"0001209191-19-038446","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119038446/doc4.xml","form_type":"4"}},{"id":3495754,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-06-10T16:13:19.000Z","date":"2019-06-06","kind":"exercise","acquired":false,"shares":5999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested as of the date hereof."}],"balance_after":103014,"derivative":{"exercise_price":7.15,"expiration_date":"2027-02-21","underlying":"Ordinary Shares","underlying_shares":5999},"source":{"system":"sec-edgar","filing":"0001209191-19-035774","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119035774/doc4.xml","form_type":"4"}},{"id":3495753,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-06-10T16:13:19.000Z","date":"2019-06-06","kind":"sale","acquired":false,"shares":5999,"price":54.786,"value":328661.214,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 6, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 5,999 shares in multiple trades at prices ranging from $54.49 to $55.14.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":185674,"source":{"system":"sec-edgar","filing":"0001209191-19-035774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119035774/doc4.xml","form_type":"4"}},{"id":3495752,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-06-10T16:13:19.000Z","date":"2019-06-06","kind":"exercise","acquired":true,"shares":5999,"price":7.15,"value":42892.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi."}],"balance_after":191673,"source":{"system":"sec-edgar","filing":"0001209191-19-035774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119035774/doc4.xml","form_type":"4"}},{"id":3498942,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-06-06T16:10:17.000Z","date":"2019-06-05","kind":"exercise","acquired":false,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested as of the date hereof."}],"balance_after":109013,"derivative":{"exercise_price":7.15,"expiration_date":"2027-02-21","underlying":"Ordinary Shares","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-19-035045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119035045/doc4.xml","form_type":"4"}},{"id":3498941,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-06-06T16:10:17.000Z","date":"2019-06-05","kind":"sale","acquired":false,"shares":17500,"price":54.142,"value":947485.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 5, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 17,500 shares in multiple trades at prices ranging from $53.86 to $54.80.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":185674,"source":{"system":"sec-edgar","filing":"0001209191-19-035045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119035045/doc4.xml","form_type":"4"}},{"id":3498940,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-06-06T16:10:17.000Z","date":"2019-06-05","kind":"exercise","acquired":true,"shares":17500,"price":7.15,"value":125125.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi."}],"balance_after":203174,"source":{"system":"sec-edgar","filing":"0001209191-19-035045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119035045/doc4.xml","form_type":"4"}},{"id":3500774,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-06-05T16:33:51.000Z","date":"2019-06-04","kind":"exercise","acquired":false,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested as of the date hereof."}],"balance_after":126513,"derivative":{"exercise_price":7.15,"expiration_date":"2027-02-21","underlying":"Ordinary Shares","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-19-034749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119034749/doc4.xml","form_type":"4"}},{"id":3500773,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-06-05T16:33:51.000Z","date":"2019-06-03","kind":"exercise","acquired":false,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested as of the date hereof."}],"balance_after":144013,"derivative":{"exercise_price":7.15,"expiration_date":"2027-02-21","underlying":"Ordinary Shares","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-19-034749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119034749/doc4.xml","form_type":"4"}},{"id":3500772,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-06-05T16:33:51.000Z","date":"2019-06-04","kind":"sale","acquired":false,"shares":200,"price":53.79,"value":10758.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On June 4, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 200 shares in multiple trades at prices ranging from $53.74 to $53.84.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":185674,"source":{"system":"sec-edgar","filing":"0001209191-19-034749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119034749/doc4.xml","form_type":"4"}},{"id":3500771,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-06-05T16:33:51.000Z","date":"2019-06-04","kind":"sale","acquired":false,"shares":17300,"price":53.113,"value":918854.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On June 4, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 17,300 shares in multiple trades at prices ranging from $52.73 to $53.70.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":185874,"source":{"system":"sec-edgar","filing":"0001209191-19-034749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119034749/doc4.xml","form_type":"4"}},{"id":3500770,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-06-05T16:33:51.000Z","date":"2019-06-04","kind":"exercise","acquired":true,"shares":17500,"price":7.15,"value":125125.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi."}],"balance_after":203174,"source":{"system":"sec-edgar","filing":"0001209191-19-034749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119034749/doc4.xml","form_type":"4"}},{"id":3500769,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-06-05T16:33:51.000Z","date":"2019-06-03","kind":"sale","acquired":false,"shares":800,"price":52.698,"value":42158.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On June 3, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 800 shares in multiple trades at prices ranging from $52.65 to $52.83.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":185674,"source":{"system":"sec-edgar","filing":"0001209191-19-034749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119034749/doc4.xml","form_type":"4"}},{"id":3500768,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-06-05T16:33:51.000Z","date":"2019-06-03","kind":"sale","acquired":false,"shares":16700,"price":52.094,"value":869969.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 3, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 16,700 shares in multiple trades at prices ranging from $51.64 to $52.63.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":186474,"source":{"system":"sec-edgar","filing":"0001209191-19-034749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119034749/doc4.xml","form_type":"4"}},{"id":3500767,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-06-05T16:33:51.000Z","date":"2019-06-03","kind":"exercise","acquired":true,"shares":17500,"price":7.15,"value":125125.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi."}],"balance_after":203174,"source":{"system":"sec-edgar","filing":"0001209191-19-034749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119034749/doc4.xml","form_type":"4"}},{"id":3531591,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-05-10T16:11:43.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 20,000 ordinary shares will fully vest and become exercisable on May 8, 2022 if (i) the closing price of the Company's ordinary shares is at least $71.34 for a period of at least twenty (20) consecutive trading days at any time between May 8, 2021 and May 8, 2022 and (ii) Mr. Ambrogi has been continuously employed by the Company through May 8, 2022."}],"balance_after":20000,"derivative":{"exercise_price":47.56,"expiration_date":"2029-05-08","underlying":"Ordinary Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-028876","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119028876/doc4.xml","form_type":"4"}},{"id":3531590,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-05-10T16:11:43.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":91515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to buy 91,515 ordinary shares will fully vest and become exercisable on May 8, 2022 if (i) the closing price of the Company's ordinary shares is at least $59.45 for a period of at least twenty (20) consecutive trading days at any time between May 8, 2021 and May 8, 2022 and (ii) Mr. Ambrogi has been continuously employed by the Company through May 8, 2022."}],"balance_after":91515,"derivative":{"exercise_price":47.56,"expiration_date":"2029-05-08","underlying":"Ordinary Shares","underlying_shares":91515},"source":{"system":"sec-edgar","filing":"0001209191-19-028876","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119028876/doc4.xml","form_type":"4"}},{"id":3565026,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-04-03T16:25:13.000Z","date":"2019-04-02","kind":"exercise","acquired":false,"shares":15516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":14.37,"expiration_date":"2025-02-23","underlying":"Ordinary Shares","underlying_shares":15516},"source":{"system":"sec-edgar","filing":"0001209191-19-023120","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119023120/doc4.xml","form_type":"4"}},{"id":3565025,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-04-03T16:25:13.000Z","date":"2019-04-01","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Fully vested as of the date hereof."}],"balance_after":3774,"derivative":{"exercise_price":11.46,"expiration_date":"2026-02-24","underlying":"Ordinary Shares","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-19-023120","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119023120/doc4.xml","form_type":"4"}},{"id":3565024,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-04-03T16:25:13.000Z","date":"2019-04-01","kind":"exercise","acquired":false,"shares":21875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Fully vested as of the date hereof."}],"balance_after":15516,"derivative":{"exercise_price":14.37,"expiration_date":"2025-02-23","underlying":"Ordinary Shares","underlying_shares":21875},"source":{"system":"sec-edgar","filing":"0001209191-19-023120","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119023120/doc4.xml","form_type":"4"}},{"id":3565023,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-04-03T16:25:13.000Z","date":"2019-04-02","kind":"sale","acquired":false,"shares":132,"price":47.833,"value":6313.956,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On April 2, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 132 shares in multiple trades at prices ranging from $47.81 to $47.84.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":185674,"source":{"system":"sec-edgar","filing":"0001209191-19-023120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119023120/doc4.xml","form_type":"4"}},{"id":3565022,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-04-03T16:25:13.000Z","date":"2019-04-02","kind":"sale","acquired":false,"shares":15384,"price":47.239,"value":726724.776,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On April 2, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 15,384 shares in multiple trades at prices ranging from $46.80 to $47.71.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":185806,"source":{"system":"sec-edgar","filing":"0001209191-19-023120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119023120/doc4.xml","form_type":"4"}},{"id":3565021,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-04-03T16:25:13.000Z","date":"2019-04-02","kind":"exercise","acquired":true,"shares":15516,"price":14.37,"value":222964.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi."}],"balance_after":201190,"source":{"system":"sec-edgar","filing":"0001209191-19-023120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119023120/doc4.xml","form_type":"4"}},{"id":3565020,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-04-03T16:25:13.000Z","date":"2019-04-01","kind":"sale","acquired":false,"shares":1298,"price":48.088,"value":62418.224,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On April 1, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 1,298 shares in multiple trades at prices ranging from $47.94 to $48.25.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":185674,"source":{"system":"sec-edgar","filing":"0001209191-19-023120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119023120/doc4.xml","form_type":"4"}},{"id":3565019,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-04-03T16:25:13.000Z","date":"2019-04-01","kind":"sale","acquired":false,"shares":11202,"price":47.393,"value":530896.386,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On April 1, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 11,202 shares in multiple trades at prices ranging from $46.94 to $47.94.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":186972,"source":{"system":"sec-edgar","filing":"0001209191-19-023120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119023120/doc4.xml","form_type":"4"}},{"id":3565018,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-04-03T16:25:13.000Z","date":"2019-04-01","kind":"exercise","acquired":true,"shares":12500,"price":11.46,"value":143250.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi."}],"balance_after":198174,"source":{"system":"sec-edgar","filing":"0001209191-19-023120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119023120/doc4.xml","form_type":"4"}},{"id":3565017,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-04-03T16:25:13.000Z","date":"2019-04-01","kind":"sale","acquired":false,"shares":1600,"price":48.072,"value":76915.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On April 1, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 1,600 shares in multiple trades at prices ranging from $47.92 to $48.25.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":185674,"source":{"system":"sec-edgar","filing":"0001209191-19-023120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119023120/doc4.xml","form_type":"4"}},{"id":3565016,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-04-03T16:25:13.000Z","date":"2019-04-01","kind":"sale","acquired":false,"shares":20275,"price":47.289,"value":958784.475,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On April 1, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 20,275 shares in multiple trades at prices ranging from $46.90 to $47.83.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":187274,"source":{"system":"sec-edgar","filing":"0001209191-19-023120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119023120/doc4.xml","form_type":"4"}},{"id":3565015,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-04-03T16:25:13.000Z","date":"2019-04-01","kind":"exercise","acquired":true,"shares":21875,"price":14.37,"value":314343.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi."}],"balance_after":207549,"source":{"system":"sec-edgar","filing":"0001209191-19-023120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119023120/doc4.xml","form_type":"4"}},{"id":3578438,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-03-26T16:05:56.000Z","date":"2019-03-22","kind":"grant","acquired":true,"shares":29969,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 29,969 ordinary shares will vest and become exercisable in equal installments on each of March 5, 2020, 2021, 2022 and 2023, subject to the reporting person's continued employment through such dates."}],"balance_after":29969,"derivative":{"exercise_price":47.04,"expiration_date":"2029-03-21","underlying":"Ordinary Shares","underlying_shares":29969},"source":{"system":"sec-edgar","filing":"0001209191-19-021301","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119021301/doc4.xml","form_type":"4"}},{"id":3578437,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Share Units","published_at":"2019-03-26T16:05:56.000Z","date":"2019-03-22","kind":"grant","acquired":true,"shares":16369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest on March 5, 2020, 2021 and 2022, subject to the reporting person's continued employment through such dates."}],"balance_after":185674,"source":{"system":"sec-edgar","filing":"0001209191-19-021301","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119021301/doc4.xml","form_type":"4"}},{"id":3623241,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2019-03-01T16:35:08.000Z","date":"2019-02-27","kind":"exercise","acquired":false,"shares":6174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":12345,"derivative":{"exercise_price":0,"exercise_date":"2019-02-27","underlying":"Ordinary Shares","underlying_shares":6174},"source":{"system":"sec-edgar","filing":"0001209191-19-015002","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119015002/doc4.xml","form_type":"4"}},{"id":3623240,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-03-01T16:35:08.000Z","date":"2019-02-28","kind":"sale","acquired":false,"shares":2397,"price":53.68,"value":128670.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II.  This sale is mandated by the Issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":169305,"source":{"system":"sec-edgar","filing":"0001209191-19-015002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119015002/doc4.xml","form_type":"4"}},{"id":3623239,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-03-01T16:35:08.000Z","date":"2019-02-27","kind":"exercise","acquired":true,"shares":6174,"price":52.9,"value":326604.6,"ownership":{"direct":true},"balance_after":171702,"source":{"system":"sec-edgar","filing":"0001209191-19-015002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119015002/doc4.xml","form_type":"4"}},{"id":3632248,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2019-02-26T18:00:23.000Z","date":"2019-02-22","kind":"exercise","acquired":false,"shares":31200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fully vested as of the date hereof."}],"balance_after":31199,"derivative":{"exercise_price":0,"exercise_date":"2019-02-22","underlying":"Ordinary Shares","underlying_shares":31200},"source":{"system":"sec-edgar","filing":"0001209191-19-013683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119013683/doc4.xml","form_type":"4"}},{"id":3632247,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-26T18:00:23.000Z","date":"2019-02-25","kind":"sale","acquired":false,"shares":12230,"price":53.628,"value":655870.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II.  This sale is mandated by the Issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":165528,"source":{"system":"sec-edgar","filing":"0001209191-19-013683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119013683/doc4.xml","form_type":"4"}},{"id":3632246,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-26T18:00:23.000Z","date":"2019-02-22","kind":"exercise","acquired":true,"shares":31200,"price":53.38,"value":1665456.0,"ownership":{"direct":true},"balance_after":177758,"source":{"system":"sec-edgar","filing":"0001209191-19-013683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119013683/doc4.xml","form_type":"4"}},{"id":3674396,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-02-05T16:16:51.000Z","date":"2019-02-04","kind":"exercise","acquired":false,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested as of the date hereof."}],"balance_after":161513,"derivative":{"exercise_price":7.15,"expiration_date":"2027-02-21","underlying":"Ordinary Shares","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-19-007326","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119007326/doc4.xml","form_type":"4"}},{"id":3674395,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-02-05T16:16:51.000Z","date":"2019-02-01","kind":"exercise","acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested as of the date hereof."}],"balance_after":182513,"derivative":{"exercise_price":7.15,"expiration_date":"2027-02-21","underlying":"Ordinary Shares","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-19-007326","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119007326/doc4.xml","form_type":"4"}},{"id":3674394,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-05T16:16:51.000Z","date":"2019-02-04","kind":"sale","acquired":false,"shares":21000,"price":49.533,"value":1040193.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On February 4, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 21,000 shares in multiple trades at prices ranging from $49.08 to $49.75.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":146558,"source":{"system":"sec-edgar","filing":"0001209191-19-007326","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119007326/doc4.xml","form_type":"4"}},{"id":3674393,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-05T16:16:51.000Z","date":"2019-02-04","kind":"exercise","acquired":true,"shares":21000,"price":7.15,"value":150150.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi."}],"balance_after":167558,"source":{"system":"sec-edgar","filing":"0001209191-19-007326","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119007326/doc4.xml","form_type":"4"}},{"id":3674392,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-05T16:16:51.000Z","date":"2019-02-01","kind":"sale","acquired":false,"shares":9840,"price":49.508,"value":487158.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 1, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 9,840 shares in multiple trades at prices ranging from $49.33 to $49.94.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":146558,"source":{"system":"sec-edgar","filing":"0001209191-19-007326","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119007326/doc4.xml","form_type":"4"}},{"id":3674391,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-05T16:16:51.000Z","date":"2019-02-01","kind":"sale","acquired":false,"shares":27660,"price":48.861,"value":1351495.26,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 1, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 27,660 shares in multiple trades at prices ranging from $48.33 to $49.32.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":156398,"source":{"system":"sec-edgar","filing":"0001209191-19-007326","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119007326/doc4.xml","form_type":"4"}},{"id":3674390,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-05T16:16:51.000Z","date":"2019-02-01","kind":"exercise","acquired":true,"shares":37500,"price":7.15,"value":268125.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi."}],"balance_after":184058,"source":{"system":"sec-edgar","filing":"0001209191-19-007326","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119007326/doc4.xml","form_type":"4"}},{"id":3696475,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-01-14T16:34:15.000Z","date":"2019-01-10","kind":"exercise","acquired":false,"shares":54930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested as of the date hereof."}],"balance_after":37391,"derivative":{"exercise_price":14.37,"expiration_date":"2025-02-23","underlying":"Ordinary Shares","underlying_shares":54930},"source":{"system":"sec-edgar","filing":"0001209191-19-003550","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119003550/doc4.xml","form_type":"4"}},{"id":3696474,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-01-14T16:34:15.000Z","date":"2019-01-10","kind":"sale","acquired":false,"shares":34050,"price":41.14,"value":1400817.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On January 10, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 34,050 shares in multiple trades at prices ranging from $41.00 to $41.45.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":146558,"source":{"system":"sec-edgar","filing":"0001209191-19-003550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119003550/doc4.xml","form_type":"4"}},{"id":3696473,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-01-14T16:34:15.000Z","date":"2019-01-10","kind":"sale","acquired":false,"shares":20880,"price":40.469,"value":844992.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 10, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 20,880 shares in multiple trades at prices ranging from $40.00 to $40.99.  The price reported above reflects the weighted average sale price.  Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":180608,"source":{"system":"sec-edgar","filing":"0001209191-19-003550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119003550/doc4.xml","form_type":"4"}},{"id":3696472,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-01-14T16:34:15.000Z","date":"2019-01-10","kind":"exercise","acquired":true,"shares":54930,"price":14.37,"value":789344.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi."}],"balance_after":201488,"source":{"system":"sec-edgar","filing":"0001209191-19-003550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119003550/doc4.xml","form_type":"4"}},{"id":3697351,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-01-11T16:18:29.000Z","date":"2019-01-09","kind":"exercise","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested as of the date hereof."}],"balance_after":16274,"derivative":{"exercise_price":11.46,"expiration_date":"2026-02-24","underlying":"Ordinary Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-003415","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119003415/doc4.xml","form_type":"4"}},{"id":3697350,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-01-11T16:18:29.000Z","date":"2019-01-09","kind":"exercise","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested as of the date hereof."}],"balance_after":92321,"derivative":{"exercise_price":14.37,"expiration_date":"2025-02-23","underlying":"Ordinary Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-19-003415","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119003415/doc4.xml","form_type":"4"}},{"id":3697349,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-01-11T16:18:29.000Z","date":"2019-01-09","kind":"sale","acquired":false,"shares":25000,"price":40,"value":1000000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi."}],"balance_after":146558,"source":{"system":"sec-edgar","filing":"0001209191-19-003415","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119003415/doc4.xml","form_type":"4"}},{"id":3697348,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":147644,"kind":"person","name":"Ambrogi Michael J.","position":1,"cik":"0001654363","reported_name":"Ambrogi Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-01-11T16:18:29.000Z","date":"2019-01-09","kind":"exercise","acquired":true,"shares":25000,"price":11.46,"value":286500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi."}],"balance_after":171558,"source":{"system":"sec-edgar","filing":"0001209191-19-003415","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654363/000120919119003415/doc4.xml","form_type":"4"}}],"next_cursor":"2019-01-11T16:18:29.000000Z,3697348"}